Jinjoo Kang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An integrative approach for exploring the nature of fibroepithelial neoplasms.
Journal: British journal of cancer
Published: January 27, 2022
CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.
Journal: Oncogene
Published: October 21, 2020
Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts.
Journal: Nature communications
Published: October 12, 2020
Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers.
Journal: Cancer letters
Published: July 20, 2020
Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 23, 2018
A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers.
Journal: Molecular cancer therapeutics
Published: November 02, 2016
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts.
Journal: Molecules and cells
Published: December 17, 2015
Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 25, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026